NCT03631719View on ClinicalTrials.gov

Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia

CompletedOBSERVATIONAL

Enrollment

834

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

DengueChikungunya Virus InfectionZika Virus Infection

Interventions

BIOLOGICAL

Wolbachia-carrying Ae.aegypti mosquitoes

Wolbachia-infected Ae. aegypti mosquito eggs and adults sequentially deployed into Medellin and Bello, Colombia. Deployments cease once Wolbachia prevalence has reached a predetermined frequency (usually ≥60%).

Trial Locations (1)

Unknown

Universidad de Antioquia, Medellín

All Listed Sponsors

collaborator

Monash University

OTHER

collaborator

United States Agency for International Development (USAID)

FED

collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Wellcome Trust

OTHER

lead

Universidad de Antioquia

OTHER

NCT03631719 - Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia | Biotech Hunter | Biotech Hunter